• Consensus Rating: Buy
  • Consensus Price Target: $57.50
  • Forecasted Upside: 14.75 %
  • Number of Analysts: 18
  • Breakdown:
  • 0 Sell Ratings
  • 9 Hold Ratings
  • 9 Buy Ratings
  • 0 Strong Buy Ratings
▲ +1.82 (3.77%)

This chart shows the closing price for PFE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Pfizer Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PFE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PFE

Analyst Price Target is $57.50
▲ +14.75% Upside Potential
This price target is based on 18 analysts offering 12 month price targets for Pfizer in the last 3 months. The average price target is $57.50, with a high forecast of $76.00 and a low forecast of $45.00. The average price target represents a 14.75% upside from the last price of $50.11.

This chart shows the closing price for PFE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 18 investment analysts is to buy stock in Pfizer. This rating has held steady since June 2022, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 5 buy ratings
  • 10 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 10 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 2 buy ratings
  • 10 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 5 buy ratings
  • 8 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 9 buy ratings
  • 9 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 9 buy ratings
  • 10 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 9 buy ratings
  • 9 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 9 buy ratings
  • 9 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 9 buy ratings
  • 9 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/9/2022BarclaysBoost Price Target$52.00Low
8/1/2022BarclaysBoost Price TargetEqual Weight$50.00 ➝ $52.00Low
7/29/2022The Goldman Sachs GroupSet Price Target$50.00Low
7/29/2022SVB LeerinkLower Price TargetMarket Perform$55.00 ➝ $53.00Low
7/13/2022The Goldman Sachs GroupSet Price Target$51.00Low
7/8/2022Morgan StanleyLower Price TargetEqual Weight$52.00 ➝ $49.00N/A
7/7/2022BarclaysSet Price Target$52.00N/A
6/28/2022JPMorgan Chase & Co.Set Price Target$57.00Low
6/27/2022BarclaysSet Price Target$52.00Low
5/27/2022Berenberg BankSet Price Target$50.00Low
5/25/2022The Goldman Sachs GroupSet Price Target$51.00Low
5/23/2022SVB LeerinkInitiated CoverageMarket Perform$55.00Low
5/19/2022Berenberg BankSet Price Target$50.00High
5/17/2022BarclaysSet Price Target$52.00Low
5/4/2022BarclaysSet Price Target$52.00Medium
5/4/2022The Goldman Sachs GroupSet Price Target$51.00Medium
5/4/2022Wells Fargo & CompanyLower Price Target$60.00 ➝ $55.00Low
5/3/2022JPMorgan Chase & Co.Set Price Target$57.00Low
4/21/2022Berenberg BankSet Price Target$50.00Medium
4/6/2022Morgan StanleyInitiated CoverageEqual Weight$55.00Medium
4/5/2022CitigroupBoost Price TargetNeutral$46.00 ➝ $57.00N/A
2/10/2022Morgan StanleyLower Price TargetEqual Weight$60.00 ➝ $55.00Medium
2/10/2022MizuhoLower Price Target$56.00 ➝ $55.00Medium
2/9/2022BarclaysSet Price Target$54.00Low
2/8/2022JPMorgan Chase & Co.Set Price Target$57.00Low
2/8/2022The Goldman Sachs GroupSet Price TargetNeutral$51.00 ➝ $54.00Low
1/28/2022JPMorgan Chase & Co.Boost Price TargetNeutral$53.00 ➝ $57.00Low
1/14/2022BMO Capital MarketsBoost Price Target$60.00 ➝ $76.00Low
1/11/2022BarclaysSet Price Target$54.00Low
1/10/2022The Goldman Sachs GroupSet Price Target$51.00Low
1/7/2022Wells Fargo & CompanyBoost Price TargetOverweight$60.00 ➝ $65.00Low
1/5/2022Bank of AmericaUpgradeNeutral ➝ Buy$59.00 ➝ $70.00Low
1/4/2022The Goldman Sachs GroupSet Price Target$51.00High
1/4/2022BarclaysSet Price Target$54.00High
1/3/2022Sanford C. BernsteinBoost Price TargetMarket Perform$44.00 ➝ $65.00Medium
12/29/2021The Goldman Sachs GroupSet Price Target$51.00High
12/29/2021BarclaysSet Price Target$54.00High
12/23/2021BarclaysSet Price Target$54.00High
12/23/2021The Goldman Sachs GroupSet Price Target$51.00Medium
12/20/2021CowenBoost Price TargetOutperform ➝ Outperform$56.00 ➝ $70.00Medium
12/17/2021The Goldman Sachs GroupInitiated CoverageNeutral$51.00High
12/16/2021BarclaysSet Price Target$54.00High
12/15/2021SVB LeerinkBoost Price TargetMarket Perform$52.00 ➝ $56.00High
12/14/2021MizuhoBoost Price TargetNeutral ➝ Neutral$44.00 ➝ $56.00High
12/14/2021Berenberg BankReiterated RatingHold$54.00Medium
12/13/2021JPMorgan Chase & Co.Set Price Target$53.00Low
12/13/2021UBS GroupUpgradeNeutral ➝ Buy$52.00 ➝ $60.00High
12/10/2021BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$44.00 ➝ $54.00High
12/8/2021Wells Fargo & CompanyInitiated CoverageOverweight$60.00Medium
11/29/2021JPMorgan Chase & Co.Boost Price TargetNeutral$42.00 ➝ $53.00High
11/29/2021Morgan StanleyBoost Price TargetSell ➝ Equal Weight$50.00 ➝ $60.00High
11/24/2021Truist FinancialBoost Price TargetBuy$43.00 ➝ $58.00Low
11/18/2021BMO Capital MarketsInitiated CoverageOutperform$60.00High
11/17/2021BarclaysSet Price Target$44.00High
11/11/2021Independent ResearchUpgradeBuy$53.00Low
11/5/2021Cantor FitzgeraldReiterated RatingBuy$60.00Low
11/5/2021BenchmarkBoost Price TargetBuy$29.00 ➝ $45.00Low
11/5/2021JPMorgan Chase & Co.Set Price Target$42.00High
11/3/2021BarclaysSet Price Target$44.00Medium
11/3/2021SVB LeerinkLower Price TargetMarket Perform$50.00 ➝ $48.00High
10/12/2021Morgan StanleyBoost Price TargetEqual Weight$45.00 ➝ $48.00Low
10/3/2021MizuhoReiterated RatingHold$43.00Medium
9/20/2021SVB LeerinkBoost Price TargetMarket Perform$49.00 ➝ $50.00High
9/14/2021SVB LeerinkReiterated RatingHold$49.00Low
9/13/2021JPMorgan Chase & Co.Boost Price TargetNeutral$40.00 ➝ $42.00High
7/30/2021MizuhoBoost Price TargetNeutral$42.00 ➝ $43.00Low
7/29/2021The Goldman Sachs GroupSet Price Target$48.00Low
7/29/2021Morgan StanleyBoost Price TargetEqual Weight$42.00 ➝ $45.00Low
7/29/2021Royal Bank of CanadaSet Price Target$44.00Low
7/29/2021SVB LeerinkBoost Price TargetMarket Perform$47.00 ➝ $49.00Low
7/27/2021Truist FinancialInitiated CoverageBuy$43.00High
6/17/2021Royal Bank of CanadaBoost Price TargetSector Perform$43.00 ➝ $44.00Low
6/15/2021Berenberg BankReiterated RatingNeutral$43.00Low
5/24/2021JPMorgan Chase & Co.Set Price TargetNeutral$40.00Low
5/24/2021The Goldman Sachs GroupSet Price TargetNeutral$45.00Low
5/13/2021The Goldman Sachs GroupReiterated RatingNeutral$45.11Low
5/12/2021MizuhoReiterated RatingBuy ➝ Neutral$42.00Low
5/10/2021Morgan StanleyBoost Price TargetEqual Weight$38.00 ➝ $42.00Low
5/6/2021MizuhoDowngradeBuy ➝ Neutral$42.00Low
5/5/2021SVB LeerinkBoost Price TargetMarket Perform$39.00 ➝ $43.00High
5/5/2021JPMorgan Chase & Co.Boost Price TargetNeutral$36.00 ➝ $40.00Medium
5/5/2021BarclaysBoost Price TargetEqual Weight$37.00 ➝ $40.00Medium
4/7/2021Royal Bank of CanadaInitiated CoverageSector Perform$42.00Low
4/6/2021The Goldman Sachs GroupSet Price TargetNeutral$41.00Low
3/31/2021The Goldman Sachs GroupSet Price TargetNeutral$41.00Low
3/26/2021SVB LeerinkLower Price TargetMarket Perform$40.00 ➝ $39.00Medium
3/23/2021Berenberg BankReiterated RatingNeutral$38.00Medium
3/15/2021The Goldman Sachs GroupSet Price TargetNeutral$41.00Medium
3/9/2021The Goldman Sachs GroupReiterated RatingNeutral$41.00Low
2/3/2021JPMorgan Chase & Co.Set Price TargetNeutral$36.00Low
2/3/2021DZ BankReiterated RatingHold ➝ Buy$41.00Low
2/3/2021SVB LeerinkLower Price TargetMarket Perform$44.00 ➝ $40.00Low
2/3/2021MizuhoLower Price TargetBuy$44.00 ➝ $42.00Low
1/29/2021Morgan StanleyLower Price TargetEqual Weight$40.00 ➝ $38.00Medium
1/21/2021The Goldman Sachs GroupSet Price TargetNeutral$40.00Low
1/8/2021The Goldman Sachs GroupSet Price TargetNeutral$40.00Low
1/4/2021Royal Bank of CanadaSet Price TargetNeutral$42.00N/A
12/29/2020Royal Bank of CanadaReiterated RatingNeutral$42.00N/A
12/16/2020Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$43.00 ➝ $42.00N/A
12/11/2020The Goldman Sachs GroupSet Price TargetNeutral$40.00Low
12/4/2020BarclaysBoost Price TargetEqual Weight$35.00 ➝ $37.00Low
12/2/2020BarclaysSet Price TargetNeutral$35.00Medium
12/2/2020Royal Bank of CanadaSet Price TargetBuy$43.00Low
12/2/2020The Goldman Sachs GroupSet Price TargetNeutral$40.00Low
11/19/2020The Goldman Sachs GroupInitiated CoverageNeutral$40.00Medium
11/10/2020Sanford C. BernsteinInitiated CoverageMarket Perform$42.00High
11/10/2020MizuhoBoost Price TargetBuy$43.00 ➝ $44.00High
11/9/2020BarclaysReiterated RatingNeutral$35.00High
11/9/2020JPMorgan Chase & Co.Set Price TargetNeutral$36.00High
10/28/2020SVB LeerinkBoost Price TargetMarket Perform$42.00 ➝ $43.00High
10/23/2020Truist FinancialInitiated CoverageBuy$42.00Low
10/16/2020Royal Bank of CanadaSet Price TargetBuy$43.00Low
10/12/2020Atlantic SecuritiesDowngradeOverweight ➝ Neutral$44.00 ➝ $39.00Low
9/29/2020Berenberg BankInitiated CoverageHold$38.00Low
9/15/2020MizuhoReiterated RatingBuy$43.00Low
9/9/2020Royal Bank of CanadaSet Price TargetBuy$43.00Low
7/30/2020Morgan StanleyBoost Price TargetEqual Weight$36.00 ➝ $42.00Low
7/29/2020UBS GroupBoost Price TargetNeutral$37.00 ➝ $39.00Low
7/29/2020SVB LeerinkBoost Price TargetMarket Perform$39.00 ➝ $42.00Low
7/28/2020MizuhoReiterated RatingPositive ➝ Buy$38.00Low
7/21/2020Morgan StanleyReiterated RatingHold$36.00High
7/20/2020Royal Bank of CanadaReiterated RatingBuy$43.00High
6/29/2020MizuhoInitiated CoverageBuy$38.00Low
6/26/2020Piper SandlerBoost Price Target$18.50 ➝ $24.00Medium
6/16/2020SVB LeerinkInitiated CoverageMarket Perform$40.00Low
6/1/2020BarclaysLower Price Target$37.00 ➝ $35.00Medium
6/1/2020JPMorgan Chase & Co.Lower Price TargetNeutral$37.00 ➝ $36.00High
5/18/2020MizuhoReiterated RatingBuy$42.00Low
4/29/2020BarclaysBoost Price TargetEqual Weight$36.00 ➝ $37.00Low
4/27/2020Royal Bank of CanadaReiterated RatingBuy$44.00Medium
4/26/2020MizuhoReiterated RatingBuy$42.00High
4/2/2020Morgan StanleyLower Price TargetEqual Weight$43.00 ➝ $36.00Medium
3/27/2020Royal Bank of CanadaLower Price TargetOutperform$46.00 ➝ $44.00Low
3/19/2020Cantor FitzgeraldReiterated RatingBuy$53.00High
3/18/2020MizuhoReiterated RatingBuy$42.00High
2/27/2020Standpoint ResearchUpgradeHold ➝ BuyHigh
2/27/2020BarclaysInitiated CoverageEqual Weight$36.00Medium
2/5/2020MizuhoInitiated CoverageBuy$42.00Low
1/29/2020Cantor FitzgeraldReiterated RatingBuy$53.00Low
1/28/2020JPMorgan Chase & Co.Reiterated RatingNeutral$37.00Low
1/6/2020Royal Bank of CanadaInitiated CoverageOutperform$46.00Medium
11/6/2019Credit Suisse GroupReiterated RatingHold$41.30Low
10/29/2019JPMorgan Chase & Co.Reiterated RatingNeutralHigh
10/16/2019Bank of AmericaInitiated CoverageNeutral$37.00Low
9/19/2019JPMorgan Chase & Co.Boost Price TargetNeutral$37.00 ➝ $46.00Low
8/28/2019DZ BankUpgradeSell ➝ Hold$36.00Medium
8/27/2019Morgan StanleyLower Price TargetEqual Weight$40.00 ➝ $38.00High
8/27/2019DZ BankReiterated RatingHold ➝ NeutralMedium
8/12/2019Credit Suisse GroupReiterated RatingHold ➝ NeutralHigh
8/5/2019UBS GroupReiterated RatingNeutral$43.00High
7/30/2019Bank of AmericaDowngradeBuy ➝ NeutralHigh
7/30/2019Morgan StanleyDowngradeOverweight ➝ Equal Weight$48.00 ➝ $40.00High
7/29/2019JPMorgan Chase & Co.Set Price TargetNeutral$46.00High
7/23/2019JPMorgan Chase & Co.Reiterated RatingNeutral$46.00Low
7/15/2019Credit Suisse GroupInitiated CoverageHold$47.00Low
6/17/2019Credit Suisse GroupReiterated RatingBuy$48.00Low
6/17/2019The Goldman Sachs GroupReiterated RatingBuy$49.00Low
6/17/2019JPMorgan Chase & Co.Reiterated RatingHold$46.00Low
6/4/2019Morgan StanleyInitiated CoverageOverweight ➝ Overweight$48.00Low
5/28/2019The Goldman Sachs GroupInitiated CoverageConviction-BuyLow
5/9/2019BarclaysReiterated RatingHold$41.00Low
5/6/2019Credit Suisse GroupReiterated RatingBuy$48.00Medium
4/30/2019JPMorgan Chase & Co.Set Price TargetNeutral$46.00Low
4/19/2019JPMorgan Chase & Co.Reiterated RatingNeutral$46.00N/A
4/1/2019Bank of AmericaBoost Price TargetBuy ➝ Buy$45.00 ➝ $48.00Low
2/20/2019CitigroupReiterated RatingSell ➝ Neutral$41.00Medium
2/19/2019Cantor FitzgeraldReiterated RatingBuy$53.00Low
1/31/2019ArgusUpgradeHold ➝ Buy$55.00Medium
1/31/2019Credit Suisse GroupUpgradeNeutral ➝ OutperformMedium
1/28/2019Credit Suisse GroupReiterated RatingNeutral$45.00High
1/23/2019UBS GroupDowngradeBuy ➝ NeutralLow
1/1/2019Credit Suisse GroupSet Price TargetNeutral$45.00Medium
12/30/2018Cantor FitzgeraldSet Price TargetBuy$53.00Low
12/26/2018Credit Suisse GroupSet Price TargetNeutral$45.00High
12/20/2018Credit Suisse GroupReiterated RatingNeutral$45.00Low
12/13/2018Credit Suisse GroupSet Price TargetHold$45.00Medium
12/11/2018Cantor FitzgeraldReiterated RatingBuy$53.00Low
12/11/2018JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$46.00Low
11/27/2018Atlantic SecuritiesReiterated RatingBuy$54.00Medium
11/26/2018Credit Suisse GroupSet Price TargetHold$42.00Medium
11/19/2018Cantor FitzgeraldReiterated RatingBuy$53.00Low
11/8/2018Cantor FitzgeraldSet Price TargetBuy$53.00Low
11/6/2018CitigroupBoost Price TargetSell ➝ Sell$34.00 ➝ $37.00Medium
11/1/2018BMO Capital MarketsDowngradeOutperform ➝ Market Perform$47.00 ➝ $46.00Medium
11/1/2018Societe GeneraleSet Price TargetHold$43.00Medium
10/30/2018Credit Suisse GroupReiterated RatingNeutral ➝ Neutral$40.00Low
10/30/2018The Goldman Sachs GroupReiterated RatingNeutral$45.00Low
10/30/2018JPMorgan Chase & Co.Reiterated RatingBuyLow
10/23/2018Wolfe ResearchInitiated CoverageMarket PerformLow
10/19/2018BarclaysSet Price TargetNeutral$40.00Low
10/17/2018Cantor FitzgeraldReiterated RatingBuy$53.00Low
10/14/2018Credit Suisse GroupSet Price TargetHold$40.00Low
10/9/2018MorningstarSet Price TargetNeutral$46.00Low
10/4/2018Cantor FitzgeraldSet Price TargetBuy$45.00Low
10/4/2018Independent ResearchSet Price TargetNeutral$48.00Low
10/1/2018JPMorgan Chase & Co.Set Price TargetBuy$46.00Low
9/27/2018MorningstarSet Price TargetBuy$46.00Low
9/26/2018BarclaysReiterated RatingNeutral$40.00Low
9/26/2018Cantor FitzgeraldSet Price TargetBuy$45.00Low
9/13/2018Morgan StanleySet Price TargetBuy$45.00Medium
9/13/2018Cantor FitzgeraldSet Price TargetBuy$45.00Medium
9/10/2018JPMorgan Chase & Co.Set Price TargetBuy$42.00Medium
9/7/2018BMO Capital MarketsBoost Price TargetOutperform$47.00Medium
9/6/2018Credit Suisse GroupSet Price TargetHold$40.00Low
9/6/2018Morgan StanleySet Price TargetBuy$45.00Low
8/29/2018BarclaysSet Price TargetNeutral$40.00Low
8/29/2018Morgan StanleySet Price TargetBuy$45.00Low
8/28/2018Credit Suisse GroupSet Price TargetNeutral$40.00Low
8/28/2018The Goldman Sachs GroupReiterated RatingNeutral$45.00Low
8/28/2018MorningstarSet Price TargetBuy$46.00Low
8/27/2018BMO Capital MarketsReiterated RatingBuy$44.00Low
8/27/2018Cantor FitzgeraldSet Price TargetBuy$45.00High
8/23/2018JPMorgan Chase & Co.Reiterated RatingBuy$42.00Low
8/23/2018BarclaysBoost Price TargetEqual Weight ➝ Neutral$38.00 ➝ $40.00Low
8/23/2018Morgan StanleySet Price TargetOverweight ➝ Buy$43.00 ➝ $45.00Low
8/21/2018Deutsche Bank AktiengesellschaftSet Price TargetBuy$42.00 ➝ $45.00Low
8/13/2018Cantor FitzgeraldSet Price TargetBuy$45.00Low
8/10/2018SunTrust BanksBoost Price TargetHold$41.00Low
8/8/2018MorningstarSet Price TargetBuy$45.00Low
8/1/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$42.00 ➝ $43.00Low
8/1/2018The Goldman Sachs GroupReiterated RatingNeutral$42.00Low
8/1/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$42.00 ➝ $44.00Medium
8/1/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$39.00 ➝ $40.00Medium
7/31/2018Jefferies Financial GroupSet Price TargetNeutral$39.00High
7/31/2018JPMorgan Chase & Co.Reiterated RatingBuyHigh
7/31/2018Credit Suisse GroupSet Price TargetHold$39.00High
7/31/2018Cantor FitzgeraldSet Price TargetBuy$45.00High
7/19/2018BMO Capital MarketsReiterated RatingBuy$42.00Low
7/18/2018JPMorgan Chase & Co.Reiterated Rating$37.66Medium
7/18/2018Cantor FitzgeraldSet Price TargetBuy$45.00Low
7/15/2018Jefferies Financial GroupSet Price TargetHold$39.00Low
7/12/2018Credit Suisse GroupSet Price TargetNeutral$39.00Low
7/11/2018Cantor FitzgeraldSet Price TargetBuy$45.00Low
7/11/2018JPMorgan Chase & Co.Reiterated RatingBuy$42.00Low
7/9/2018Jefferies Financial GroupReiterated RatingNeutral$39.00Medium
6/13/2018Cantor FitzgeraldSet Price TargetBuy$45.00Low
6/11/2018Morgan StanleyReiterated RatingBuy$43.00Low
6/11/2018Credit Suisse GroupSet Price TargetNeutral$39.00Low
6/7/2018Cantor FitzgeraldInitiated CoverageOverweight$45.00Low
5/30/2018Societe GeneraleReiterated RatingNeutral$39.00Low
5/18/2018Credit Suisse GroupReiterated RatingNeutral$39.00Low
5/14/2018Jefferies Financial GroupReiterated RatingNeutral$39.00Low
5/8/2018JPMorgan Chase & Co.Set Price TargetBuy$42.00Low
5/3/2018DZ BankReiterated RatingSellLow
5/2/2018MorningstarSet Price TargetBuy$43.50Low
5/2/2018BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$43.00 ➝ $42.00Low
5/2/2018JPMorgan Chase & Co.Reiterated RatingBuy$42.00Medium
4/13/2018Jefferies Financial GroupSet Price TargetHold$38.00Low
4/12/2018CitigroupReiterated RatingSellMedium
4/11/2018Berenberg BankReiterated RatingNeutral$37.00Low
4/5/2018BarclaysDowngradeOverweight ➝ Equal Weight$41.00 ➝ $38.00Medium
4/2/2018BMO Capital MarketsSet Price TargetBuy$43.00Medium
3/6/2018BMO Capital MarketsSet Price TargetBuy$43.00Low
2/26/2018Jefferies Financial GroupSet Price TargetHold$39.00Low
2/15/2018BMO Capital MarketsSet Price TargetBuy$43.00Low
2/5/2018BMO Capital MarketsSet Price TargetBuy$43.00High
1/31/2018BarclaysBoost Price TargetOverweight ➝ Overweight$38.00 ➝ $41.00Medium
1/31/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$37.00 ➝ $39.00Medium
1/31/2018SVB LeerinkBoost Price TargetMarket Perform ➝ Market Perform$35.00 ➝ $38.00Medium
1/31/2018UBS GroupSet Price TargetBuy$42.00Medium
1/31/2018Morgan StanleyBoost Price TargetOverweight ➝ Buy$41.00 ➝ $43.00Medium
1/31/2018Societe GeneraleSet Price TargetNeutral$40.00Medium
1/30/2018The Goldman Sachs GroupSet Price TargetNeutral$36.00High
1/30/2018MorningstarSet Price TargetNeutral$38.00High
1/30/2018Bank of AmericaSet Price TargetBuy$40.00Medium
1/30/2018JPMorgan Chase & Co.Reiterated RatingBuyLow
1/30/2018Sanford C. BernsteinSet Price TargetBuy$43.00Low
1/30/2018Berenberg BankSet Price TargetNeutral$36.00Low
1/30/2018BMO Capital MarketsSet Price TargetBuy$39.00High
1/29/2018SunTrust BanksReiterated RatingHold ➝ Hold$33.00 ➝ $40.00Low
1/24/2018BMO Capital MarketsSet Price TargetBuy$39.00Low
1/16/2018Jefferies Financial GroupSet Price TargetNeutral$40.00Low
1/8/2018BMO Capital MarketsSet Price TargetBuy$39.00Low
1/5/2018Morgan StanleySet Price TargetBuy$41.00Low
1/2/2018Nord/LBReiterated RatingNeutralLow
12/27/2017Nord/LBReiterated RatingNeutralLow
12/15/2017BMO Capital MarketsSet Price TargetBuy$39.00Low
12/8/2017BMO Capital MarketsSet Price TargetBuy$39.00Low
12/6/2017UBS GroupSet Price TargetBuy$40.00Low
12/6/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy$38.00Low
11/25/2017BMO Capital MarketsSet Price TargetBuy$39.00Low
11/16/2017Jefferies Financial GroupSet Price TargetNeutral$39.00N/A
11/10/2017BMO Capital MarketsReiterated RatingBuy$39.00N/A
11/1/2017JPMorgan Chase & Co.Set Price TargetBuy$39.00N/A
11/1/2017Jefferies Financial GroupSet Price TargetNeutral$39.00N/A
11/1/2017The Goldman Sachs GroupSet Price TargetNeutral$36.00N/A
11/1/2017UBS GroupSet Price TargetBuy$38.00N/A
10/31/2017Berenberg BankSet Price TargetNeutral$36.00N/A
10/31/2017BMO Capital MarketsSet Price TargetBuy$39.00N/A
10/26/2017Jefferies Financial GroupSet Price TargetNeutral$39.00N/A
10/19/2017BMO Capital MarketsReiterated RatingBuy$37.00 ➝ $39.00N/A
10/16/2017Jefferies Financial GroupSet Price TargetNeutral$38.00N/A
10/11/2017Deutsche Bank AktiengesellschaftSet Price TargetBuy$38.00N/A
10/11/2017BarclaysSet Price TargetBuy$38.00N/A
10/10/2017BMO Capital MarketsSet Price TargetBuy$37.00N/A
9/20/2017Morgan StanleyUpgradeEqual Weight ➝ Overweight$35.00 ➝ $39.00Low
9/19/2017Sanford C. BernsteinSet Price TargetBuy$39.00Low
9/18/2017Jefferies Financial GroupSet Price TargetNeutral$37.00Low
9/14/2017BMO Capital MarketsReiterated RatingBuy$37.00High
9/6/2017BMO Capital MarketsReiterated RatingBuy$37.00Low
8/24/2017Jefferies Financial GroupSet Price TargetNeutral$35.00Low
8/18/2017Jefferies Financial GroupReiterated RatingHold$35.00Low
8/15/2017Berenberg BankReiterated RatingHold$39.00 ➝ $36.00Low
8/14/2017CowenSet Price TargetBuy$43.00Low
(Data available from 8/12/2017 forward)

News Sentiment Rating

0.24 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 20 very positive mentions
  • 84 positive mentions
  • 16 negative mentions
  • 6 very negative mentions
  • 26 very positive mentions
  • 86 positive mentions
  • 13 negative mentions
  • 5 very negative mentions
  • 13 very positive mentions
  • 63 positive mentions
  • 8 negative mentions
  • 1 very negative mentions
  • 11 very positive mentions
  • 56 positive mentions
  • 11 negative mentions
  • 7 very negative mentions
  • 17 very positive mentions
  • 66 positive mentions
  • 12 negative mentions
  • 3 very negative mentions
  • 21 very positive mentions
  • 67 positive mentions
  • 9 negative mentions
  • 5 very negative mentions
  • 20 very positive mentions
  • 49 positive mentions
  • 10 negative mentions
  • 2 very negative mentions
  • 19 very positive mentions
  • 70 positive mentions
  • 8 negative mentions
  • 7 very negative mentions

Current Sentiment

  • 19 very positive mentions
  • 70 positive mentions
  • 8 negative mentions
  • 7 very negative mentions

Recent Stories by Sentiment

Pfizer logo
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Read More

Today's Range

Now: $50.11
Low: $48.55
High: $50.39

50 Day Range

MA: $50.80
Low: $46.53
High: $53.96

52 Week Range

Now: $50.11
Low: $40.94
High: $61.71


25,618,705 shs

Average Volume

27,205,629 shs

Market Capitalization

$281.16 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Pfizer?

The following Wall Street analysts have issued reports on Pfizer in the last twelve months: Bank of America Co., Barclays PLC, Benchmark Co., Berenberg Bank, BMO Capital Markets, Cantor Fitzgerald, Citigroup Inc., Cowen Inc, Independent Research GmbH, JPMorgan Chase & Co., Mizuho, Morgan Stanley, Sanford C. Bernstein, StockNews.com, SVB Leerink LLC, The Goldman Sachs Group, Inc., Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for PFE.

What is the current price target for Pfizer?

18 Wall Street analysts have set twelve-month price targets for Pfizer in the last year. Their average twelve-month price target is $57.50, suggesting a possible upside of 14.7%. BMO Capital Markets has the highest price target set, predicting PFE will reach $76.00 in the next twelve months. Benchmark Co. has the lowest price target set, forecasting a price of $45.00 for Pfizer in the next year.
View the latest price targets for PFE.

What is the current consensus analyst rating for Pfizer?

Pfizer currently has 9 hold ratings and 9 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe PFE will outperform the market and that investors should add to their positions of Pfizer.
View the latest ratings for PFE.

What other companies compete with Pfizer?

How do I contact Pfizer's investor relations team?

Pfizer's physical mailing address is 235 EAST 42ND STREET, NEW YORK NY, 10017. The biopharmaceutical company's listed phone number is (212) 733-2323. The official website for Pfizer is www.pfizer.com. Learn More about contacing Pfizer investor relations.